Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 04, 2016 08:30 ET | Source: Remedy Pharmaceuticals

Remedy Pharmaceuticals Announces Successful Completion of End-of-Phase 2 Meeting With FDA on a Novel Drug Treatment for CNS-Related Edema

NEW YORK, March 04, 2016 (GLOBE NEWSWIRE) -- Remedy Pharmaceuticals, a privately-held, pharmaceutical company focused on bringing life saving hospital-based treatment to people affected by central...
February 22, 2016 07:30 ET | Source: Remedy Pharmaceuticals

Remedy Pharmaceuticals Announces Additional Results From Phase 2 CNS-Related Edema Study of CIRARA™ Presented at International Stroke Conference

A more than three-fold reduction in mortality in patients ≤70 years old; adjudicated neurological mortality reduced more than three-fold, and death from edema reduced 10-fold. Results...
February 16, 2016 08:30 ET | Source: Remedy Pharmaceuticals

Remedy Pharmaceuticals Announces FDA Orphan Drug Designation in Two CNS Indications

NEW YORK, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Remedy Pharmaceuticals, a privately-held, Phase 3-ready pharmaceutical company focused on bringing life saving hospital-based treatment to people...
February 08, 2016 09:35 ET | Source: Remedy Pharmaceuticals

Remedy Pharmaceuticals Announces Acceptance of Two Oral Presentations on Phase 2 Results of CIRARA™ for CNS-Related Edema at ISC 2016

NEW YORK, Feb. 08, 2016 (GLOBE NEWSWIRE) -- Remedy Pharmaceuticals, a privately-held, phase 3-ready pharmaceutical company focused on bringing life saving hospital-based treatment to people affected...